ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Cefepime Hydrochloride Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting Feb 10, 2026 · last update Feb 10, 2026

Manufacturers: Fresenius Kabi USA, LLC

Stated reasons (per FDA): Not stated

More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)Fresenius Kabi USA, LLCTo Be Discontinued
—Discontinuation of the manufacture of the drug.Posted Feb 10, 2026
Updated Feb 10, 2026
Discontinued Feb 10, 2026
Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)Fresenius Kabi USA, LLCTo Be Discontinued
—Discontinuation of the manufacture of the drug.Posted Feb 10, 2026
Updated Feb 10, 2026
Discontinued Feb 10, 2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)

Free, weekly, unsubscribe anytime. Privacy.